Skip to main content

Table 1 Baseline characteristics of patients in the model construction cohort

From: Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors

  Values
Subject number 327
Age 44.21 ± 11.22
Gender
  Male 280 (85.63%)
  Female 47 (14.37%)
Liver Histology
 ISHAK Fibrosis Stages
  0 2 (0.61%)
  1 40 (12.23%)
  2 51 (15.60%)
  3 110 (33.64%)
  4 33 (10.09%)
  5 74 (22.63%)
  6 17 (5.20%)
 Piecemeal necrosis
  0 101 (30.89%)
  1 165 (50.46%)
  2 47 (14.37%)
  3 14 (4.28%)
 Confluent necrosis
  0 307 (93.88%)
  1 6 (1.83%)
  2 2 (0.61%)
  3 1 (0.31%)
  4 10 (3.06%)
  5 1 (0.31%)
 Focal (spotty) lytic necrosis, apoptosis and focal inflammation
  0 2 (0.61%)
  1 93 (28.44%)
  2 161 (49.24%)
  3 67 (20.49%)
  4 4 (1.22%)
 Portal inflammation
  0 6 (1.83%)
  1 77 (23.55%)
  2 103 (31.50%)
  3 123 (37.61%)
  4 17 (5.20%)
  5 1 (0.31%)
 Viral serology
  HBV DNA (log10 IU/ml) 6.35 ± 1.71
  HBeAg positive 146 (44.65%)
  HBsAg (log10 IU/ml) 3.33 ± 0.98
 Hematology
  ALT (IU/L) 177.31 ± 173.34
  AST (IU/L) 106.96 ± 122.57
  Bilirubin (mg/dL) 0.98 ± 0.42
  Albumin (g/dL) 4.55 ± 0.35
  Gamma-glutamyltransferase (IU/L) 59.53 ± 46.75
  Platelet (1000/mm3) 189.78 ± 50.31
  Hemoglobin (g/dL) 15.20 ± 1.36